Europe cannot afford to lose the race for biomedical innovation

As clinical trials and investment increasingly turn elsewhere, European patients are missing out on breakthrough treatments. Policy can make a real difference here.

To respect copyright, we link to the source rather than republishing the full text. Read the complete article on Politico Europe.